PE-backed Strand Life Sciences to buy Quest Diagnostics' India medical diagnostics business

Quest Diagnostics has agreed to sell its India medical diagnostics business to Strand Life Sciences, a portfolio company of Quadria Capital. No financial terms were disclosed. The deal is expected to close by the end of the first quarter of 2019.

9 October 2018•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles